Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 12:55PM ET
93.82
Dollar change
-0.04
Percentage change
-0.04
%
Index- P/E32.24 EPS (ttm)2.91 Insider Own34.96% Shs Outstand145.16M Perf Week-0.47%
Market Cap12.92B Forward P/E27.46 EPS next Y3.42 Insider Trans-0.12% Shs Float89.54M Perf Month8.49%
Income427.20M PEG2.28 EPS next Q0.46 Inst Own82.28% Short Float4.04% Perf Quarter27.43%
Sales2.96B P/S4.36 EPS this Y6.41% Inst Trans-11.09% Short Ratio4.43 Perf Half Y50.67%
Book/sh9.49 P/B9.89 EPS next Y24.47% ROA10.87% Short Interest3.62M Perf Year23.10%
Cash/sh3.55 P/C26.45 EPS next 5Y14.15% ROE34.30% 52W Range53.79 - 94.86 Perf YTD27.69%
Dividend Est.0.15 (0.16%) P/FCF53.11 EPS past 5Y20.48% ROI16.35% 52W High-1.09% Beta1.17
Dividend TTM0.20 (0.21%) Quick Ratio0.99 Sales past 5Y9.74% Gross Margin51.17% 52W Low74.43% ATR (14)1.91
Dividend Ex-DateFeb 29, 2024 Current Ratio1.80 EPS Y/Y TTM46.17% Oper. Margin16.27% RSI (14)71.03 Volatility1.76% 2.19%
Employees9707 Debt/Eq1.00 Sales Y/Y TTM17.14% Profit Margin14.41% Recom2.00 Target Price85.50
Option/ShortYes / Yes LT Debt/Eq0.90 EPS Q/Q113.71% Payout6.89% Rel Volume0.20 Prev Close93.86
Sales Surprise5.83% EPS Surprise2.44% Sales Q/Q20.62% EarningsFeb 13 BMO Avg Volume816.50K Price93.82
SMA202.30% SMA5014.35% SMA20032.82% Trades Volume90,119 Change-0.04%
Date Action Analyst Rating Change Price Target Change
Feb-14-24Upgrade JP Morgan Neutral → Overweight $60 → $90
Dec-19-23Initiated Wells Fargo Equal Weight $72
Dec-13-23Initiated Wolfe Research Outperform $80
Oct-21-22Initiated UBS Buy $70
Aug-22-22Upgrade Citigroup Neutral → Buy $70 → $80
Oct-15-21Resumed Cowen Market Perform $68
Jun-15-21Upgrade Cleveland Research Neutral → Buy
Feb-05-21Downgrade Wells Fargo Overweight → Equal Weight $50 → $55
Dec-02-20Initiated Goldman Sell $50
Nov-16-20Upgrade Wolfe Research Underperform → Peer Perform
Mar-22-24 09:48AM
Mar-14-24 11:30AM
09:08AM
Mar-12-24 07:51AM
Mar-11-24 07:00AM
07:00AM Loading…
Mar-07-24 07:00AM
Mar-06-24 05:01PM
Mar-05-24 08:23AM
Mar-01-24 08:39AM
Feb-28-24 07:00AM
Feb-26-24 05:00PM
05:00PM
10:52AM
10:42AM
09:37AM
02:00PM Loading…
Feb-17-24 02:00PM
Feb-16-24 04:05PM
Feb-15-24 09:07AM
Feb-14-24 10:03AM
02:06AM
Feb-13-24 09:30AM
08:45AM
07:51AM
07:49AM
07:00AM
Feb-12-24 12:10PM
09:14AM
Feb-07-24 07:00AM
Feb-06-24 04:05PM
07:00AM
07:00AM Loading…
Feb-05-24 07:00AM
Feb-01-24 10:00AM
Jan-30-24 01:36PM
Jan-29-24 10:41AM
Jan-25-24 07:00AM
Jan-23-24 08:00AM
Jan-16-24 11:22AM
Jan-11-24 12:10PM
Jan-05-24 08:05AM
Jan-04-24 08:00AM
08:00AM
Jan-03-24 04:35PM
07:00AM
Dec-27-23 07:34AM
Dec-20-23 11:32AM
Dec-19-23 09:41AM
Nov-28-23 07:50AM
Nov-27-23 09:15AM
Nov-20-23 04:15PM
Nov-07-23 09:00AM
Nov-06-23 07:18AM
Nov-04-23 01:25PM
Nov-02-23 09:18AM
07:33AM
07:00AM
Oct-27-23 11:07AM
Oct-26-23 10:02AM
Oct-20-23 12:10PM
Oct-12-23 08:13AM
Oct-05-23 08:32AM
Oct-04-23 08:47AM
07:00AM
Oct-03-23 07:00AM
Oct-02-23 04:05PM
Sep-19-23 01:09PM
Sep-18-23 07:00AM
Sep-15-23 04:06AM
Sep-12-23 11:48AM
Sep-08-23 07:54AM
Sep-07-23 07:00AM
Sep-06-23 07:43AM
Sep-05-23 04:02PM
Aug-24-23 04:05PM
06:21AM
Aug-18-23 11:09AM
Aug-17-23 09:00AM
Aug-16-23 04:05PM
Aug-14-23 07:00AM
Aug-13-23 09:35AM
Aug-04-23 09:45AM
12:51AM
Aug-03-23 11:40PM
11:30AM
08:35AM
07:24AM
07:00AM
Aug-02-23 08:05AM
Jul-31-23 08:51AM
Jul-29-23 10:06AM
Jul-25-23 04:44PM
Jul-11-23 08:52AM
Jul-10-23 07:00AM
Jul-04-23 10:31AM
Jul-03-23 08:15AM
Jun-30-23 07:00AM
Jun-28-23 09:26AM
Jun-27-23 10:00AM
Jun-21-23 08:00PM
Jun-14-23 10:39AM
Jun-13-23 03:10PM
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology. The BSI CALID segment focuses on life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological and nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The BSI Nano segment offers advanced x-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, analytical tools for electron microscopes and x-ray metrology, defect-detection equipment for semiconductor process control, handheld, portable, and mobile x-ray fluorescence spectrometry instruments, spark optical emission spectroscopy systems, and chip cytometry products and services for targeted spatial proteomics, multi-omics services, and products and services for spatial genomics research. The BEST segment is involved in superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company was founded by Emil Bruker and Gunther Laukien in 1960 and is headquartered in Billerica, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Requardt Hermann FritzDirectorMar 04 '24Option Exercise22.0515,000330,75038,147Mar 06 04:05 PM
Requardt Hermann FritzDirectorMar 04 '24Sale90.0615,0001,350,89823,147Mar 06 04:05 PM
Busse FalkoPRESIDENT, BIOSPIN GROUPFeb 28 '24Option Exercise26.2828,122739,15660,981Mar 01 04:05 PM
Busse FalkoPRESIDENT, BIOSPIN GROUPFeb 28 '24Sale85.4828,1222,403,89032,859Mar 01 04:05 PM
Prause BurkhardPRES. & CEO, BRUKER BESTFeb 22 '24Option Exercise43.175,450235,29232,384Feb 26 04:02 PM
Prause BurkhardPRES. & CEO, BRUKER BESTFeb 22 '24Sale83.3015,3191,276,07317,065Feb 26 04:02 PM
LINTON WILLIAM ADirectorDec 05 '23Option Exercise19.0710,000190,70033,048Dec 07 04:01 PM
LAUKIEN FRANK HPRESIDENT & CEOOct 26 '23Option Exercise46.1459,5232,746,68938,327,911Oct 30 04:11 PM
LAUKIEN FRANK HPRESIDENT & CEOAug 08 '23Option Exercise47.8544,1502,112,57838,255,291Aug 10 05:09 PM
LAUKIEN FRANK HPRESIDENT & CEOAug 08 '23Sale64.8137,9472,459,34538,217,344Aug 10 05:09 PM
LAUKIEN FRANK HPRESIDENT & CEOJul 27 '23Option Exercise37.4268,4542,561,54938,249,088Jul 31 04:10 PM
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFOJun 16 '23Sale75.4214,2421,074,13236,462Jun 20 04:31 PM
Kastner Marc ADirectorMay 19 '23Sale75.2211,146838,4028,051May 22 04:15 PM
LAUKIEN FRANK HPRESIDENT & CEOMay 16 '23Sale73.1114,6251,069,17438,180,634May 17 04:17 PM
LAUKIEN FRANK HPRESIDENT & CEOMay 15 '23Sale72.75185,37513,485,86638,262,287May 17 04:17 PM
LAUKIEN FRANK HPRESIDENT & CEOMay 09 '23Sale75.20110,9828,345,41038,100,011May 10 04:18 PM
LAUKIEN FRANK HPRESIDENT & CEOMay 08 '23Sale77.0589,0186,859,09438,210,993May 10 04:18 PM
LAUKIEN FRANK HPRESIDENT & CEOMay 03 '23Sale79.2116,4351,301,81638,352,034May 04 04:11 PM
LAUKIEN FRANK HPRESIDENT & CEOMay 02 '23Sale77.98100,7707,858,03038,161,517May 03 04:15 PM
LAUKIEN FRANK HPRESIDENT & CEOMay 01 '23Sale78.7582,7956,519,84138,262,287May 03 04:15 PM
LAUKIEN FRANK HPRESIDENT & CEOApr 25 '23Sale78.8651,7704,082,70238,262,287Apr 26 04:17 PM
LAUKIEN FRANK HPRESIDENT & CEOApr 24 '23Sale81.02148,23012,009,46138,349,926Apr 26 04:17 PM